Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors
Clinical trial NCT01628913 · TERMINATED
Trial details
- NCT number
- NCT01628913
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2014-09-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.